In vitro differentiation and biocompatibility of mesenchymal stem cells on a novel platelet releasate-containing injectable composite

Journal of Biomedical Materials Research - Part A

Volumn 100 A, Issue 1, 2012, Pages 220-229

  McCanless, Jonathan D ^a   Jennings, Lisa K ^b,c   Cole, Judith A ^d   Bumgardner, Joel D ^a,b,c   Haggard, Warren O ^a  

^a University of Memphis   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d University of Memphis   (United States)

Author keywords

alginate; mesenchymal stem cell; osteochondrogenesis; platelet releasate; tricalcium phosphate

Indexed keywords

ARTICULAR CHONDROCYTES; BONE REMODELING; CANCELLOUS BONE; CARTILAGINOUS DAMAGE; CHONDROCYTES; DELIVERABILITY; DNA QUANTIFICATION; ENDOCHONDRAL OSSIFICATION; GENE EXPRESSION PROFILES; IN-VITRO; INTERVENTION THERAPY; JOINT FAILURE; MESENCHYMAL STEM CELL; MITOGENIC ACTIVITY; NEOVASCULARIZATION; OSTEOCHONDRAL; OSTEOCHONDROGENESIS; SPINAL DISC; TRI-CALCIUM PHOSPHATES; UP-REGULATION;

ALGINATE; BIOCOMPATIBILITY; BODY FLUIDS; CELL CULTURE; GENES; NUCLEIC ACIDS; PLATELETS; STEM CELLS; TRANSCRIPTION; TRANSCRIPTION FACTORS;

BONE;

ALGINIC ACID; BIOMATERIAL; CALCIUM PHOSPHATE; MESSENGER RNA; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9;

ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BONE REMODELING; CANCELLOUS BONE; CARTILAGE CELL; CARTILAGINOUS TISSUE; CELL DIFFERENTIATION; COMPOSITE MATERIAL; CONTROLLED STUDY; GENE EXPRESSION PROFILING; IN VITRO STUDY; INFLAMMATION; MESENCHYMAL STEM CELL; MITOGENESIS; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OSSIFICATION; OSTEOLYSIS; PHENOTYPE; RAT; THROMBOCYTE; UPREGULATION;

ALGINATES; ANIMALS; BIOCOMPATIBLE MATERIALS; BLOOD PLATELETS; CALCIUM PHOSPHATES; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GLUCURONIC ACID; HEXURONIC ACIDS; INJECTIONS; MALE; MESENCHYMAL STEM CELLS; OSTEOGENESIS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE SCAFFOLDS;

EID: 81855207532     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.33256     Document Type: Article

References (47)

1. Adams MA, Roughley PJ,. What is intervertebral disc degeneration, and what causes it? Spine 2006; 31: 2151-2161.
2. Goldring SR,. The role of bone in osteoarthritis pathogenesis. Rheum Dis Clin North Am 2008; 34: 561-571.
3. Benneker LM, Heini PF, Alini M, Anderson SE, Ito K,. 2004 Young Investigator Award Winner: vertebral endplate marrow contact channel occlusions and intervertebral disc degeneration. Spine (Phila Pa 1976) 2005; 30: 167-173.
4. Bancroft LW, Peterson JJ, Kransdorf MJ,. Cysts, geodes, and erosions. Radiol Clin North Am 2004; 42: 73-87.
5. Carrino JA, Blum J, Parellada JA, Schweitzer ME, Morrison WB,. MRI of bone marrow edema-like signal in the pathogenesis of subchondral cysts. Osteoarthritis Cartilage 2006; 14: 1081-1085.
6. Brandt KD,. Diagnosis and Nonsurgical Management of Osteoarthritis, 2nd ed. Caddo, OK: Professional Communications, Inc.; 2000.
7. Kalfas IH,. Principles of bone healing. Neurosurg Focus 2001; 10: E1.
8. Remedios A,. Bone and bone healing. Vet Clin North Am Small Anim Pract 1999; 29: 1029-1044, v.
9. Kolar P, Schmidt-Bleek K, Schell H, Gaber T, Toben D, Schmidmaier G, Perka C, Buttgereit F, Duda GN,. The early fracture hematoma and its potential role in fracture healing. Tissue Eng Part B Rev 2010; 16: 427-434.
10. Klinger MH,. Platelets and inflammation. Anat Embryol (Berl) 1997; 196: 1-11.
11. Knighton DR, Ciresi KF, Fiegel VD, Austin LL, Butler EL,. Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg 1986; 204: 322-330.
12. Knighton DR, Ciresi K, Fiegel VD, Schumerth S, Butler E, Cerra F,. Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula. Surg Gynecol Obstet 1990; 170: 56-60.
13. Steed DL, Goslen JB, Holloway GA, Malone JM, Bunt TJ, Webster MW,. Randomized prospective double-blind trial in healing chronic diabetic foot ulcers. CT-102 activated platelet supernatant, topical versus placebo. Diabetes Care 1992; 15: 1598-1604.
14. Mehta S, Watson JT,. Platelet rich concentrate: basic science and current clinical applications. J Orthop Trauma 2008; 22: 432-438.
15. Beamer B, Hettrich C, Lane J,. Vascular endothelial growth factor: An essential component of angiogenesis and fracture healing. HSS J 2010; 6: 85-94.
16. Gordon S, Taylor PR,. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5: 953-964.
17. Dennis JE, Haynesworth SE, Young RG, Caplan AI,. Osteogenesis in marrow-derived mesenchymal cell porous ceramic composites transplanted subcutaneously: Effect of fibronectin and laminin on cell retention and rate of osteogenic expression. Cell Transplant 1992; 1: 23-32.
18. Lennon DP, Edmison JM, Caplan AI,. Cultivation of rat marrow-derived mesenchymal stem cells in reduced oxygen tension: Effects on in vitro and in vivo osteochondrogenesis. J Cell Physiol 2001; 187: 345-355.
19. McCanless JD, Jennings JA, Bumgardner JD, Haggard WO, editors. Could less mesenchymal stem cells benefit the degenerate nucleus pulposus more? 56th Annual Meeting Orthopaedic Research Society. New Orleans, Louisiana, 2010.
20. McCanless JD, Cole JA, Slack SM, Bumgardner JD, Zamora PO, Haggard WO,. Modeling nucleus pulposus regeneration in vitro: Mesenchymal stem cells, alginate beads, hypoxia, BMP-2, and synthetic peptide B2A. Spine (Phila Pa 1976). 2011 February 9, [Epub ahead of print].
21. Haggard WO, McCanless JD, inventors. US provisional patent application: Biomaterial composition and method of use. University of Memphis, assignee, 2011.
22. White MM, Jennings LK,. Appendix. Platelet Protocols: Research and Clinical Laboratory Procedures. San Diego: Academic Press; 1999. p 99-101.
23. Provot S, Schipani E,. Molecular mechanisms of endochondral bone development. Biochem Biophys Res Commun 2005; 328: 658-665.
24. Anitua E, Andia I, Sanchez M, Azofra J, del Mar Zalduendo M, de la Fuente M, Nurden P, Nurden AT,. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res 2005; 23: 281-286.
25. El-Sharkawy H, Kantarci A, Deady J, Hasturk H, Liu H, Alshahat M, Van Dyke TE,. Platelet-rich plasma: Growth factors and pro- and anti-inflammatory properties. J Periodontol 2007; 78: 661-669.
26. Ng F, Boucher S, Koh S, Sastry KS, Chase L, Lakshmipathy U, Choong C, Yang Z, Vemuri MC, Rao MS, Tanavde V,. PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): Transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 2008; 112: 295-307.
27. Marie PJ,. Transcription factors controlling osteoblastogenesis. Arch Biochem Biophys 2008; 473: 98-105.
28. Karsenty G, Wagner EF,. Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2002; 2: 389-406.
29. Lefebvre V, Smits P,. Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res C Embryo Today 2005; 75: 200-212.
30. Murakami S, Kan M, McKeehan WL, de Crombrugghe B,. Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 2000; 97: 1113-1118.
31. Cheng A, Genever PG,. SOX9 determines RUNX2 transactivity by directing intracellular degradation. J Bone Miner Res 2010; 25: 2680-2689.
32. Yamashita S, Andoh M, Ueno-Kudoh H, Sato T, Miyaki S, Asahara H,. Sox9 directly promotes Bapx1 gene expression to repress Runx2 in chondrocytes. Exp Cell Res 2009; 315: 2231-2240.
33. Provot S, Kempf H, Murtaugh LC, Chung UI, Kim DW, Chyung J, Kronenberg HM, Lassar AB,. Nkx3.2/Bapx1 acts as a negative regulator of chondrocyte maturation. Development 2006; 133: 651-662.
34. Shankaran H, Wiley HS, Resat H,. Receptor downregulation and desensitization enhance the information processing ability of signalling receptors. BMC Syst Biol 2007; 1: 48.
35. Sun H, Ye F, Wang J, Shi Y, Tu Z, Bao J, Qin M, Bu H, Li Y,. The upregulation of osteoblast marker genes in mesenchymal stem cells prove the osteoinductivity of hydroxyapatite/tricalcium phosphate biomaterial. Transplant Proc 2008; 40: 2645-2648.
36. Fellah BH, Gauthier O, Weiss P, Chappard D, Layrolle P,. Osteogenicity of biphasic calcium phosphate ceramics and bone autograft in a goat model. Biomaterials 2008; 29: 1177-1188.
37. Danielpour D, Kim KY, Dart LL, Watanabe S, Roberts AB, Sporn MB,. Sandwich enzyme-linked immunosorbent assays (SELISAs) quantitate and distinguish two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) in complex biological fluids. Growth Factors 1989; 2: 61-71.
38. Oida T, Weiner HL,. Depletion of TGF-beta from fetal bovine serum. J Immunol Methods 2010; 362: 195-198.
39. Worster AA, Nixon AJ, Brower-Toland BD, Williams J,. Effect of transforming growth factor beta1 on chondrogenic differentiation of cultured equine mesenchymal stem cells. Am J Vet Res 2000; 61: 1003-1010.
40. Kim YJ, Kim HN, Park EK, Lee BH, Ryoo HM, Kim SY, Kim IS, Stein JL, Lian JB, Stein GS, van Wijnen AJ, Choi JY,. The bone-related Zn finger transcription factor Osterix promotes proliferation of mesenchymal cells. Gene 2006; 366: 145-151.
41. Wen Q, Zhou L, Zhou C, Zhou M, Luo W, Ma L,. Change in hepatocyte growth factor concentration promote mesenchymal stem cell-mediated osteogenic regeneration. J Cell Mol Med. 2011 August 10. [Epub ahead of print].
42. Ferro F, Falini G, Spelat R, D'Aurizio F, Puppato E, Pandolfi M, Beltrami AP, Cesselli D, Beltrami CA, Impiombato FS, Curcio F,. Biochemical and biophysical analyses of tissue-engineered bone obtained from three-dimensional culture of a subset of bone marrow mesenchymal stem cells. Tissue Eng Part A 2010; 16: 3657-3667.
43. Wang L, Wang J, Yang D, Yang C, Xia B, Xian J,. Inhibitory effect of bone sialoprotein silencing on the adhesion ability of breast cancer cells to bone matrix. Sheng Wu Gong Cheng Xue Bao 2011; 27: 233-239.
44. Xia B, Wang J, Guo L, Jiang Z,. Effect of bone sialoprotein on proliferation and osteodifferentiation of human bone marrow-derived mesenchymal stem cells in vitro. Biologicals 2011; 39: 217-223.
45. Hudis M,. Treatment of solid materials. In:, Hollahan J, Bell A, editors. Techniques and Applications of Plasma Chemistry. New York: John Wiley; 1974. p 113-147.
46. Amstein C, Hartman P,. Adaption of plastic surfaces for tissue culture by glow discharge. In:, Andrade, editor. Surface and Interfacial Aspects of Biomedical Polymers. New York: Plenum Press; 1985.
47. Ehrenfreund-Kleinman T, Golenser J, Domb AJ,. Polysaccharide scaffolds for tissue engineering. In:, Ma PX, Elisseeff J, editors. Scaffolding in Tissue Engineering. Boca Raton, FL: CRC Press; 2006. p 27-44.